Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for infarct size reduction in STEMI undergoing primary PCI
2004-005259-32Phase 2Unknown
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Nov 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in acute ST-segment elevation myocardial infarction (STEMI), sponsored by Imperial College Healthcare NHS Trust. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2004-005259-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005259-32.